Teicoplanin Injectable (Iv/Im) Suppliers & Bulk Manufacturers
Available Forms: Injectable (IV/IM)
Available Strengths: 200 mg/100 mL, 400 mg/200 mL, 400 mg/100 mL
Reference Brands: Targocid, Tolocin(US & EU)
Category: Antibiotics
Teicoplanin Injectable (IV/IM) is available in Injectable (IV/IM) and strengths such as 200 mg/100 mL, 400 mg/200 mL, 400 mg/100 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Teicoplanin Injectable (IV/IM) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Teicoplanin Injectable (IV/IM) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Teicoplanin injectable is approved in the EU and US for severe gram-positive bacterial infections, including MRSA. In the EU, brands like Targocid are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, approval is limited, with extraregional use mainly in Europe and Asia. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety. For expert support on regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for teicoplanin IV formulations, ensuring adherence to European and US standards for safe, effective antimicrobial therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Cefiderocol
Strength:
1 g per vial
Form: Injection
Reference Brands: Fetroja (USA), Fetcroja (EU/UK)
View DetailsFidaxomicin
Strength:
200mg, 40mg/5ml
Form: Tablets / Oral suspension
Reference Brands: Dificid (USA), Dificlir (EU/UK)
View DetailsDemeclocycline Hydrochloride
Strength:
150mg, 300mg
Form: Tablets
Reference Brands: Declomycin (USA/EU)
View DetailsDapsone
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers